213 related articles for article (PubMed ID: 19440021)
1. Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma.
Serretta V; Altieri V; Morgia G; Allegro R; Ruggirello A; Di Lallo A; Carrieri G; Melloni D;
Urol Int; 2009; 82(3):318-23. PubMed ID: 19440021
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder. A study from Gruppo Studi Tumori Urologici Foundation.
Serretta V; Morgia G; Altieri V; Pavone-Macaluso M; Scuto F; Allegro R; Di Lallo A; Cindolo L; Melloni D;
Urol Int; 2006; 77(2):152-8. PubMed ID: 16888422
[TBL] [Abstract][Full Text] [Related]
3. Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors.
Yan Y; Andriole GL; Humphrey PA; Kibel AS
Cancer; 2002 Sep; 95(6):1239-46. PubMed ID: 12216091
[TBL] [Abstract][Full Text] [Related]
4. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer.
Chen CH; Shun CT; Huang KH; Huang CY; Tsai YC; Yu HJ; Pu YS
BJU Int; 2007 Aug; 100(2):281-6; discussion 286. PubMed ID: 17419696
[TBL] [Abstract][Full Text] [Related]
5. Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder.
Dearing J
Ann R Coll Surg Engl; 2005 Mar; 87(2):85-7. PubMed ID: 15826413
[TBL] [Abstract][Full Text] [Related]
6. Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer.
Zhang ZF; Sarkis AS; Cordon-Cardo C; Dalbagni G; Melamed J; Aprikian A; Pollack D; Sheinfeld J; Herr HW; Fair WR
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):19-24. PubMed ID: 8118380
[TBL] [Abstract][Full Text] [Related]
7. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.
Wallerand H; Bakkar AA; de Medina SG; Pairon JC; Yang YC; Vordos D; Bittard H; Fauconnet S; Kouyoumdjian JC; Jaurand MC; Zhang ZF; Radvanyi F; Thiery JP; Chopin DK
Carcinogenesis; 2005 Jan; 26(1):177-84. PubMed ID: 15347601
[TBL] [Abstract][Full Text] [Related]
8. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos.
Kannio A; Ridanpää M; Koskinen H; Partanen T; Anttila S; Collan Y; Hietanen E; Vainio H; Husgafvel-Pursiainen K
Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):33-9. PubMed ID: 8770464
[TBL] [Abstract][Full Text] [Related]
9. Conservative management of low risk superficial bladder tumors.
Pruthi RS; Baldwin N; Bhalani V; Wallen EM
J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
[TBL] [Abstract][Full Text] [Related]
10. Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.
Pietzak EJ; Mucksavage P; Guzzo TJ; Malkowicz SB
Urology; 2015 Nov; 86(5):968-72. PubMed ID: 26190088
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS
J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
[TBL] [Abstract][Full Text] [Related]
12. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
Guney S; Guney N; Canogullari Z; Ergenekon E
Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
[TBL] [Abstract][Full Text] [Related]
13. Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.
Bernardini S; Adessi GL; Chezy E; Billerey C; Carbillet JP; Bittard H
Anticancer Res; 2001; 21(4B):3001-4. PubMed ID: 11712801
[TBL] [Abstract][Full Text] [Related]
14. Patients with superficial transitional cell carcinoma of the bladder and their smoking status.
Smith JA
Cancer; 1999 Dec; 86(11):2192-4. PubMed ID: 10590355
[No Abstract] [Full Text] [Related]
15. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
[TBL] [Abstract][Full Text] [Related]
17. Drinking water source and chlorination byproducts. I. Risk of bladder cancer.
Cantor KP; Lynch CF; Hildesheim ME; Dosemeci M; Lubin J; Alavanja M; Craun G
Epidemiology; 1998 Jan; 9(1):21-8. PubMed ID: 9430264
[TBL] [Abstract][Full Text] [Related]
18. Association between marijuana use and transitional cell carcinoma.
Chacko JA; Heiner JG; Siu W; Macy M; Terris MK
Urology; 2006 Jan; 67(1):100-4. PubMed ID: 16413342
[TBL] [Abstract][Full Text] [Related]
19. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
[TBL] [Abstract][Full Text] [Related]
20. Superficial bladder cancer: part 1. Update on etiology, classification and natural history.
Josephson DY; Pasin E; Stein JP
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1723-34. PubMed ID: 17181486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
